GFP/RFP Stable Cell Lines

Cellomics' GFP/RFP Stable cancer cell lines express GFP/RFP reporters under different promoters, can be used for in vitro and in vivo cancer research. Non-invasive imaging of GFP/RFP labeled tumor stable cells has enabled the metastatic process be followed dynamically in real time in animals, and screening of antitumor and antimetastatic drugs in vivo.
  • Jurkat/GFP-firefly luciferase HSV1-tk stable cells
    Jurkat/GFP-firefly luciferase stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Jurkat/GFP-firefly luciferase stable cells express transgenically GFP-firefly luciferase under the control of the constitutive promoter. The cell proliferation and trafficking could be monitored with fluorescence and bioluminescence imaging in xenograft model.
    Price: $2,350.00
  • Jurkat/GFP-firefly luciferase HSV1-tk stable cells
    Jurkat/GFP-firefly luciferase-HSV1-tk stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Jurkat/GFP-firefly luciferase-HSV1-tk (CMV) stable cells express transgenically GFP-firefly luciferase-HSV1-tk under the control of the constitutive promoter. The cell proliferation and trafficking could be monitored with positron emission tomography (PET) and bioluminescence imaging in xenograft model.
    Price: $3,350.00
  • Jurkat/HSV1-tk stable cells
    Jurkat/HSV1-tk stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Jurkat/HSV1-tk stable cells express transgenically firefly luciferase. The cell proliferation and trafficking could be monitored with bioluminescience imaging in xenograft model.
    Price: $1,350.00
  • Jurkat/RFP stable cells
    Jurkat/RFP stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Jurkat/RFP stable cells express transgenically RFP under the control of the constitutive promoter. The cell proliferation and traffing could be monitored with fluorescence.
    Price: $1,350.00
  • Jurkat/RFP-firefly luciferase-t-HSV1-tk stable cells
    Jurkat/RFP-firefly luciferase-HSV1-tk stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Raw264.7/RFP-firefly luciferase-HSV1-tk stable cells express transgenically RFP-firefly luciferase-HSV1-tk under the control of the constitutive promoter. The cell proliferation and traffing could be monitored with positron emission tomography (PET) and bioluminescience imaging in xenograft model.
    Price: $3,350.00
  • Jurkat/RFP-firefly luciferase stable cells
    Jurkat/RFP-firefly luciferase-stable cells
    Jurkat, an human leukemia cell line, has been widely used in cancer research and drug development in vitro and in vivo. Raw264.7/RFP-firefly luciferase stable cells express transgenically RFP-firefly luciferase under the control of the constitutive promoter. The cell proliferation and trafficking could be monitored with fluorescence and bioluminescence imaging in xenograft model.
    Price: $2,350.00
  • K562  firefly luciferase stable cells
    Price: $1,350.00
  • K-562/firefly luciferase stable cells
    K-562/firefly luciferase stable cells
    K-562 cell line, lymphoblast derived from human myelogenous leukemia, has been widely used in cancer research and drug development in vitro and in vivo. K-562/firefly luciferase  stable cells express transgenically firefly luciferase under the control of the constitutive promoter. The proliferation and trafficking of the cells could be monitored in fluorescence/bioluminescence imaging in small animal xenograft model.
    Price: $1,350.00
  • K562  firefly luciferase-GFP stable cells
    Price: $1,350.00
  • K562  GFP stable cells
    Price: $1,350.00
  • K-562/GFP stable cells
    K-562/GFP stable cells
    K-562 cell line, lymphoblast derived from human myelogenous leukemia, has been widely used in cancer research and drug development in vitro and in vivo. K-562/GFP stable cells express transgenically GFP under the control of the constitutive promoter. The proliferation and trafficking of the cells could be monitored in fluorescence imaging in small animal xenograft model.
    Price: $1,350.00
  • K-562/GFP-firefly luciferase stable cells
    K-562/GFP-firefly luciferase stable cells
    K-562 cell line, lymphoblast derived from human myelogenous leukemia, has been widely used in cancer research and drug development in vitro and in vivo. K-562/GFP-firefly luciferase  stable cells express transgenically GFP-firefly luciferase under the control of the constitutive promoter. The proliferation and trafficking of the cells could be monitored in fluorescence/bioluminescence imaging in small animal xenograft model.
    Price: $2,350.00
  • K-562/GFP-firefly luciferase-HSV1-tk (CMV)  stable cells
    K-562/GFP-firefly luciferase-HSV1-tk (CMV) stable cells
    K-562 cell line, lymphoblast derived from human myelogenous leukemia, has been widely used in cancer research and drug development in vitro and in vivo. K-562/GFP-firefly luciferase (CMV) stable cells express transgenically GFP-firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in fluorescence/bioluminescence imaging in small animal xenograft model.
    Price: $3,350.00
  • K-562/HSV1-tk (CMV)  stable cells
    K-562/HSV1-tk (CMV) stable cells
    K-562 cell line, lymphoblast derived from human myelogenous leukemia, has been widely used in cancer research and drug development in vitro and in vivo. K-562/HSV1-tk (CMV) stable cells express transgenically HSV1-tk under the control of the CMV promoter. The cell proliferation and trafficing in small animal xenograft model can be imaged with positron emission tomography (PET) technology.
    Price: $1,350.00
  • K-562/HSV1-tk-firefly luciferase (CMV)  stable cells
    K-562/HSV1-tk-firefly luciferase (CMV) stable cells
    K-562 cell line, lymphoblast derived from human myelogenous leukemia, has been widely used in cancer research and drug development in vitro and in vivo. K-562/HSV1-tk-firefly luciferase (CMV) stable cells express transgenically HSV1-tk/firefly luciferase under the control of the CMV promoter. The cell proliferation and trafficking could be monitored with PET and bioluminescence imaging.
    Price: $2,350.00
  • K562  RFP stable cells
    Price: $1,350.00
  • K-562/RFP stable cells
    K-562/RFP stable cells
    K-562 cell line, lymphoblast derived from human myelogenous leukemia, has been widely used in cancer research and drug development in vitro and in vivo. K-562/RFP stable cells express transgenically RFP under the control of the constitutive promoter. The proliferation and trafficking of the cells could be monitored in fluorescence imaging in small animal xenograft model.
    Price: $1,350.00
  • K-562/RFP-firefly luciferase (CMV)  stable cells
    K-562/RFP-firefly luciferase (CMV) stable cells
    K-562 cell line, lymphoblast derived from human myelogenous leukemia, has been widely used in cancer research and drug development in vitro and in vivo. K-562/RFP-firefly luciferase (CMV) stable cells express transgenically RFP-firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in fluorescence/bioluminescence imaging in small animal xenograft model.
    Price: $2,350.00
  • K-562/RFP-firefly luciferase-HSV1-tk (CMV)  stable cells
    K-562/RFP-firefly luciferase-HSV1-tk (CMV) stable cells
    K-562 cell line, lymphoblast derived from human myelogenous leukemia, has been widely used in cancer research and drug development in vitro and in vivo. K-562/RFP-firefly luciferase-HSV1-tk (CMV) stable cells express transgenically RFP-firefly luciferase-HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence, bioluminescience and PET.
    Price: $3,350.00
  • KASUMI-1/firefly luciferase (CMV)  stable cells
    KASUMI-1/firefly luciferase (CMV) stable cells
    KASUMI-1 cell line, myeloblast derived from human myeloblast leukemia, has been widely used in cancer research and drug development in vitro and in vivo. KASUMI-1/firefly luciferase (CMV) stable cells express transgenically firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in Bioluminescence imaging in small animal xenograft model.
    Price: $3,200.00
  • KASUMI-1/GFP (CMV)  stable cells
    KASUMI-1/GFP (CMV) stable cells
    KASUMI-1 cell line, myeloblast derived from human myeloblast leukemia, has been widely used in cancer research and drug development in vitro and in vivo. KASUMI-1/GFP (CMV) stable cells express transgenically GFP under the control of the CMV promoter. The proliferation and trafficing of these cells in samll animal could be monitored by small animal xenograft model fluorescence imaging.
    Price: $3,200.00
  • KASUMI-1/GFP-firefly luciferase (CMV)  stable cells
    KASUMI-1/GFP-firefly luciferase (CMV) stable cells
    KASUMI-1 cell line, myeloblast derived from human myeloblast leukemia, has been widely used in cancer research and drug development in vitro and in vivo. KASUMI-1/GFP-firefly luciferase (CMV) stable cells express transgenically firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in fluorescence/bioluminescence imaging in small animal xenograft model.
    Price: $4,200.00
  • KASUMI-1/GFP-firefly luciferase-HSV1-tk (CMV)  stable cells
    KASUMI-1/GFP-firefly luciferase-HSV1-tk (CMV) stable cells
    KASUMI-1 cell line, myeloblast derived from human myeloblast leukemia, has been widely used in cancer research and drug development in vitro and in vivo. KASUMI-1/GFP-firefly luciferase (CMV) stable cells express transgenically GFP-firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in fluorescence/bioluminescence imaging in small animal xenograft model.
    Price: $5,200.00
  • KASUMI-1/HSV1-tk (CMV)  stable cells
    KASUMI-1/HSV1-tk (CMV) stable cells
    KASUMI-1 cell line, myeloblast derived from human myeloblast leukemia, has been widely used in cancer research and drug development in vitro and in vivo. KASUMI-1/HSV1-tk (CMV) stable cells express transgenically HSV1-tk under the control of the CMV promoter. The cell proliferation and trafficing in small animal xenograft model can be imaged with positron emission tomography (PET) technology.
    Price: $3,200.00
  • KASUMI-1/HSV1-tk-firefly luciferase (CMV)  stable cells
    KASUMI-1/HSV1-tk-firefly luciferase (CMV) stable cells
    KASUMI-1 cell line, myeloblast derived from human myeloblast leukemia, has been widely used in cancer research and drug development in vitro and in vivo. KASUMI-1/HSV1-tk-firefly luciferase (CMV) stable cells express transgenically HSV1-tk/firefly luciferase under the control of the CMV promoter. The cell proliferation and trafficking could be monitored with PET and bioluminescence imaging.
    Price: $4,200.00
  • KASUMI-1/RFP (CMV)  stable cells
    KASUMI-1/RFP (CMV) stable cells
    KASUMI-1 cell line, myeloblast derived from human myeloblast leukemia, has been widely used in cancer research and drug development in vitro and in vivo. KASUMI-1/RFP (CMV) stable cells express transgenically RFP under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence imaging.
    Price: $3,200.00
  • KASUMI-1/RFP-firefly luciferase (CMV)  stable cells
    KASUMI-1/RFP-firefly luciferase (CMV) stable cells
    KASUMI-1 cell line, myeloblast derived from human myeloblast leukemia, has been widely used in cancer research and drug development in vitro and in vivo. KASUMI-1/RFP-firefly luciferase (CMV) stable cells express transgenically RFP-firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in fluorescence/bioluminescence imaging in small animal xenograft model.
    Price: $4,200.00
  • KASUMI-1/RFP-firefly luciferase-HSV1-tk (CMV)  stable cells
    KASUMI-1/RFP-firefly luciferase-HSV1-tk (CMV) stable cells
    KASUMI-1 cell line, myeloblast derived from human myeloblast leukemia, has been widely used in cancer research and drug development in vitro and in vivo. KASUMI-1/RFP-firefly luciferase-HSV1-tk (CMV) stable cells express transgenically RFP-firefly luciferase-HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence, bioluminescience and PET.
    Price: $5,200.00
  • LL/2/firefly luciferase (CMV)  stable cells
    LL/2/firefly luciferase (CMV) stable cells
    LL/2, a mouse lung carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LL/2/firefly luciferase (CMV) stable cells express transgenically firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in Bioluminescence imaging in small animal xenograft model.
    Price: $1,350.00
  • LL/2/GFP (CMV)  stable cells
    LL/2/GFP (CMV) stable cells
    LL/2 , a mouse lung carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LL/2/GFP (CMV) stable cells express transgenically GFP under the control of the CMV promoter. The proliferation and trafficing of these cells in samll animal could be monitored by small animal xenograft model fluorescence imaging.
    Price: $1,350.00
  • LL/2/GFP-firefly luciferase (CMV)  stable cells
    LL/2/GFP-firefly luciferase (CMV) stable cells
    LL/2, a mouse lung carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LL/2/GFP-firefly luciferase (CMV) stable cells express transgenically firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in fluorescence/bioluminescence imaging in small animal.
    Price: $2,350.00
  • LL/2/GFP-firefly luciferase-HSV1-tk (CMV)  stable cells
    LL/2/GFP-firefly luciferase-HSV1-tk (CMV) stable cells
    LL/2, a mouse lung carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LL/2/GFP-firefly luciferase (CMV) stable cells express transgenically GFP-firefly luciferase under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence, bioluminescience imaging. The proliferation and trafficing of the cells could be monitored in fluorescence/bioluminescence imaging in small animal xenograft model.
    Price: $3,350.00
  • LL/2/HSV1-tk (CMV)  stable cells
    LL/2/HSV1-tk (CMV) stable cells
    LL/2, a mouse lung carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LL/2/HSV1-tk (CMV) stable cells express transgenically HSV1-tk under the control of the CMV promoter. The cell proliferation and trafficing in small animal xenograft model can be imaged with positron emission tomography (PET) technology.
    Price: $1,350.00
  • LL/2/HSV1-tk-firefly luciferase (CMV)  stable cells
    LL/2/HSV1-tk-firefly luciferase (CMV) stable cells
    LL/2, a mouse lung carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LL/2/HSV1-tk-firefly luciferase (CMV) stable cells express transgenically HSV1-tk/firefly luciferase under the control of the CMV promoter. The cell proliferation and trafficking could be monitored with PET and bioluminescence imaging.
    Price: $2,350.00
  • LL/2/RFP (CMV)  stable cells
    LL/2/RFP (CMV) stable cells
    LL/2, a mouse lung carcinoma cell line, widely used in cancer research and drug development in vitro and in vivo. LL/2/RFP (CMV) stable cells express transgenically RFP under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence imaging.
    Price: $1,350.00
  • LL/2/RFP-firefly luciferase (CMV)  stable cells
    LL/2/RFP-firefly luciferase (CMV) stable cells
    LL/2, a mouse lung carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LL/2/RFP-firefly luciferase (CMV) stable cells express transgenically RFP-firefly luciferase under the control of the CMV promoter. The proliferation and trafficing of the cells could be monitored in fluorescence/bioluminescence imaging in small animal.
    Price: $2,350.00
  • LL/2/RFP-firefly luciferase-t-HSV1-tk (CMV)  stable cells
    LL/2/RFP-firefly luciferase-t-HSV1-tk (CMV) stable cells
    LL/2, a mouse lung carcinoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LL/2/RFP-firefly luciferase-HSV1-tk (CMV) stable cells express transgenically RFP-firefly luciferase-HSV1-tk under the control of the CMV promoter. The proliferation and trafficking of these cells could be monitored with fluorescence, bioluminescience and PET.
    Price: $3,350.00
  • LN-229  GFP stable cells
    Price: $1,350.00
  • LN229/CreGFP (CMV)  stable cells
    LN229/CreGFP (CMV) stable cells
    LN229, a human glioblastoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LN229/CreGFP (CMV) stable cells express transgenically CreGFP under the control of the CMV promoter. The proliferation and trafficing of these cells in samll animal could be monitored by small animal xenograft model fluorescence imaging.
    Price: $1,350.00
  • LN229/CreRFP (CMV)  stable cells
    LN229/CreRFP (CMV) stable cells
    LN229, a human glioblastoma cell line, has been widely used in cancer research and drug development in vitro and in vivo. LN229/CreRFP (CMV) stable cells express transgenically CreRFP under the control of the CMV promoter. The proliferation and trafficing of these cells in samll animal could be monitored by small animal xenograft model fluorescence imaging.
    Price: $1,350.00
Loading...